Sooft Italia clinical trials
Acquired by Fidia Farmaceutici s.p.a.
The registry lists 3 studies whose lead sponsor is Sooft Italia. 0 are recruiting or about to start. Per ClinicalTrials.gov, last updated Nov 2, 2020.
Status
- Withdrawn
- 3
Where
- Italy
- 3
Registry sponsor names on this page
- Sooft Italia3 studies
Something wrong with this grouping? Tell us on the Fidia Farmaceutici s.p.a. page.
Studies
Recruiting first, then most recently updated. Showing 3 of 3. All Fidia Farmaceutici s.p.a. studies →
- Early Administration of the Lutein/Zeaxanthin in Premature NewbornsWithdrawnNCT03340103Not applicable
Sponsor listed in the registry: Sooft Italia · Sooft Italia — acquired company within the Fidia Farmaceutici s.p.a. group
- Effects of Forskolin on Intraocular Pressure in Glaucomatous Patients Under Maximum Tolerated Medical TherapyWithdrawnNCT00864578
Sponsor listed in the registry: Sooft Italia · Sooft Italia — acquired company within the Fidia Farmaceutici s.p.a. group
- Effects of Forskolin on Intraocular Pressure in Glaucomatous Patients Under Treatment With Either Beta-blockers or Prostaglandins Eye DropsWithdrawnNCT00863811
Sponsor listed in the registry: Sooft Italia · Sooft Italia — acquired company within the Fidia Farmaceutici s.p.a. group